Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > CrISPR
View:
Post by Metalsguy1 on Jun 27, 2021 2:00pm

CrISPR

https://www.npr.org/sections/health-shots/2021/06/26/1009817539/he-inherited-a-devastating-disease-a-crispr-gene-editing-breakthrough-stopped-it
Comment by Mudlogger1 on Jun 27, 2021 3:28pm
I get using gene editing for deterministic inherited disease...but does that apply to diabetes? Can you gene edit ahead of time or after the fact for lifestyle?  Wouldn't you need to edit for boxes of donuts, buckets of alcohol, lack of exercise? Just asking. The story is incredible and that Irish guy hit the jackpot...just not sure that a brittle diabetic and the multiple factors ...more  
Comment by Redbaron2211 on Jun 27, 2021 6:48pm
CRISPR isn't a threat to treating TD1. First the gene has to be discovered if it's even a gene that causes td1. It's still a mystery and will likely remain so for some time.
Comment by Metalsguy1 on Jun 27, 2021 9:44pm
More ignorance from the peanut gallery. Are you sharing your nuts with mudslinger red? If Gene editing can't be used to address the disease how can the company be using gene editing to protect beta cell transplants.
Comment by Redbaron2211 on Jun 27, 2021 11:29pm
Metal there might be some success in treating T1D with gene edited IPSC cells but this only highlights the relevance of the pouch.  To prevent the damage before it happens with CRISPR we would need to know what gene causes T1D.   This is far from clear and most speculate it is a combination of both genetics and environmental factors.   An example being identical twins with ...more  
Comment by Metalsguy1 on Jun 28, 2021 2:27am
Red. My point is that with the glacial pace that SVA chooses to follow, even something as challenging as using CRISPR , just about anything is possible. Mudslinger things science is slow but if science were really this slow we would still not have a polio vaccine.
Comment by Metalsguy1 on Jun 27, 2021 9:41pm
Obviously, you do have a lot in common with turnips. Type 1 diabetes has nothing to do with lifestyle. It is an autoimmune disease. Since you don't understand the very basic mechanism of type 1 diabetes, I won't waste my time explaining the various pathways that CRISPR could be used.
Comment by Mudlogger1 on Jun 28, 2021 8:05am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities